Technical Analysis for DARE - Dare Bioscience, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 14.29% | |
Narrow Range Bar | Range Contraction | 14.29% | |
BB Squeeze Started | Range Contraction | 14.29% | |
Crossed Above 20 DMA | Bullish | 14.21% |
Alert | Time |
---|---|
Up 2 ATRs | about 14 hours ago |
Up 10% | about 17 hours ago |
Up 1 ATR | about 17 hours ago |
Possible Pocket Pivot | about 17 hours ago |
60 Minute Opening Range Breakout | about 18 hours ago |
Get a Trading Assistant
- Earnings date: 05/09/2024
Dare Bioscience, Inc. Description
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Drugs Birth Control Vagina Women's Health Diaphragm Hormonal Contraception Medroxyprogesterone Acetate
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.03 |
52 Week Low | 0.27 |
Average Volume | 669,941 |
200-Day Moving Average | 0.44 |
50-Day Moving Average | 0.41 |
20-Day Moving Average | 0.31 |
10-Day Moving Average | 0.32 |
Average True Range | 0.04 |
RSI (14) | 53.05 |
ADX | 17.13 |
+DI | 28.84 |
-DI | 16.49 |
Chandelier Exit (Long, 3 ATRs) | 0.38 |
Chandelier Exit (Short, 3 ATRs) | 0.39 |
Upper Bollinger Bands | 0.34 |
Lower Bollinger Band | 0.27 |
Percent B (%b) | 1.27 |
BandWidth | 22.72 |
MACD Line | -0.02 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0099 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.46 | ||||
Resistance 3 (R3) | 0.46 | 0.42 | 0.44 | ||
Resistance 2 (R2) | 0.42 | 0.40 | 0.42 | 0.44 | |
Resistance 1 (R1) | 0.39 | 0.38 | 0.41 | 0.39 | 0.43 |
Pivot Point | 0.36 | 0.36 | 0.37 | 0.36 | 0.36 |
Support 1 (S1) | 0.33 | 0.33 | 0.34 | 0.33 | 0.29 |
Support 2 (S2) | 0.29 | 0.32 | 0.29 | 0.28 | |
Support 3 (S3) | 0.26 | 0.29 | 0.28 | ||
Support 4 (S4) | 0.26 |